熱門資訊> 正文

Ensemble Life Sciences任命Alexander Tokman为代理首席执行官

2024-08-13 20:28

ENDRA Life Sciences (NASDAQ:NDRA) said it has appointed Alexander Tokman as its acting CEO to replace Francois Michelon.
Michelon has stepped down from the helm to pursue other endeavors.
The company has also named Richard Jacroux as its finance chief.
Tokman and Jacroux both have over two decades of experience.

More on Endra Life Sciences

Seeking Alpha’s Quant Rating on Endra Life Sciences
Historical earnings data for Endra Life Sciences
Financial information for Endra Life Sciences

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。